🔬
Foundation Sciences · Biochemistry

Fatty Acid Beta-Oxidation

⏱️ 45–60 minutes read 📖 Biochemistry

Mitochondrial degradation of fatty acids to acetyl-CoA, NADH and FADH2; requires carnitine shuttle for long-chain FAs.

📌 Learning Objectives

  • Describe the key principles of fatty acid beta-oxidation.
  • Explain the clinical relevance of fatty acid beta-oxidation.
  • Recognise common conditions linked to fatty acid beta-oxidation in MLA-style scenarios.

📋 Overview

Mitochondrial degradation of fatty acids to acetyl-CoA, NADH and FADH2; requires carnitine shuttle for long-chain FAs. This topic integrates with pathology, pharmacology and clinical medicine and is frequently tested in UK medical school exams and the MLA.

🔬 Basic Science

Mitochondrial degradation of fatty acids to acetyl-CoA, NADH and FADH2; requires carnitine shuttle for long-chain FAs. Detailed mechanisms, regulation and molecular interactions underpin both normal physiology and disease.

🏥 Clinical Relevance

MCAD on newborn screen; avoid fasting; emergency dextrose.

🧪 Investigations

Relevant laboratory tests, imaging or histological examination are used as appropriate to the clinical context.

💊 Management

Management is condition-specific; principles include addressing the underlying biochemical/structural derangement, supportive care and targeted therapy where available.

Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.

🎯 MLA High-Yield Notes & Quick Revision
High-yield topic for the UK MLA — frequently appears in SBA questions linking biochemistry concepts to clinical presentations and management decisions.
Applying biomedical science to clinical practice Diagnosis and investigation Pathophysiology of common conditions
  • Mitochondrial degradation of fatty acids to acetyl-CoA, NADH and FADH2
  • requires carnitine shuttle for long-chain FAs.
Exam Pearls
⭐ High Yield
CPT-I rate-limiting, inhibited by malonyl-CoA
Each cycle: 1 FADH2, 1 NADH, 1 acetyl-CoA
MCAD deficiency: hypoketotic hypoglycaemia in infants
Carnitine deficiency → muscle weakness, cardiomyopathy
💡 Clinical Pearl
: MCAD on newborn screen; avoid fasting; emergency dextrose.
⚠️ Exam Tip — Common Mistakes
Confusing fatty acid beta-oxidation with related but distinct mechanisms.
Memorising pathways without linking to clinical disease.
🔑 Key Facts
CPT-I rate-limiting, inhibited by malonyl-CoA
Each cycle: 1 FADH2, 1 NADH, 1 acetyl-CoA
MCAD deficiency: hypoketotic hypoglycaemia in infants
Carnitine deficiency → muscle weakness, cardiomyopathy
📚 References
  1. BMJ Best Practice
  2. Robbins Basic Pathology
  3. Lippincott Illustrated Reviews: Biochemistry
  4. Wheater's Functional Histology
  5. NICE guidance where applicable.

Further Resources

Medical Portfolio & Career Development

Build a professional portfolio website for applications, audits, teaching, research and career progression.

CVtoWebsite.com →